1-3 of 3
Nam Bui
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Disruption of NSD1 in Head and Neck Cancer Promotes Favorable Chemotherapeutic Responses Linked to Hypomethylation

Nam Bui, Justin K. Huang, Ana Bojorquez-Gomez, Katherine Licon, Kyle S. Sanchez, Sean N. Tang, Alex N. Beckett, Tina Wang, Wei Zhang, John Paul Shen, Jason F. Kreisberg, Trey Ideker
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (7): 1585–1594.
https://doi.org/10.1158/1535-7163.MCT-17-0937
Published: 01 July 2018
View article titled, Disruption of <em>NSD1</em> in Head and Neck Cancer Promotes Favorable Chemotherapeutic Responses Linked to Hypomethylation
Open the PDF for Disruption of <em>NSD1</em> in Head and Neck Cancer Promotes Favorable Chemotherapeutic Responses Linked to Hypomethylation in another window
Includes: Supplementary data
Journal Articles

Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology

Hatim Husain, David Nykin, Nam Bui, Daniel Quan, German Gomez, Brian Woodward, Sumathi Venkatapathy, Radha Duttagupta, Eric Fung, Scott M. Lippman, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2017) 16 (5): 948–955.
https://doi.org/10.1158/1535-7163.MCT-16-0436
Published: 02 May 2017
View article titled, Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology
Open the PDF for Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology in another window
Includes: Supplementary data
Journal Articles

Strategies to Overcome Bypass Mechanisms Mediating Clinical Resistance to EGFR Tyrosine Kinase Inhibition in Lung Cancer

Hatim Husain, Michael Scur, Ayesha Murtuza, Nam Bui, Brian Woodward, Razelle Kurzrock
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (2): 265–272.
https://doi.org/10.1158/1535-7163.MCT-16-0105
Published: 02 February 2017
View article titled, Strategies to Overcome Bypass Mechanisms Mediating Clinical Resistance to EGFR Tyrosine Kinase Inhibition in Lung Cancer
Open the PDF for Strategies to Overcome Bypass Mechanisms Mediating Clinical Resistance to EGFR Tyrosine Kinase Inhibition in Lung Cancer in another window